Loading…
3 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Amb Group | (unclassified) | 12.4% | 54th pct | 1208 |
| Mshenebeli 2004 | Fitness & Wellness | 13.1% | 53rd pct | 30 |
| Tsekuri | Construction | 0.1% | 23rd pct | 582 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | Tsekuri | Mshenebeli 2004 | Amb Group |
|---|---|---|---|
| Margins | |||
| Gross Margin | 1.7% | 36.6% | 53.3% |
| EBITDA Margin | 0.1% | 13.1% | 12.4% |
| EBITDAR | 144 | 294 | 191 |
| EBITDAR Margin | 0.2% | 13.1% | 13.5% |
| EBIT Margin | 0.1% | 7.9% | 5.7% |
| Net Profit Margin | -5.5% | 7.9% | 5.4% |
| Operating Expense % of Sales | 1.7% | 23.5% | 40.9% |
| Returns | |||
| Return on Assets (ROA) | -14.1% | 5.3% | 7.5% |
| Return on Equity (ROE) | -43.8% | 5.7% | N/A |
| ROIC [EBIT / Invested Capital] | 0.5% | 5.5% | N/A |
| Leverage & debt balances | |||
| Debt-to-Assets | 13.0% | 3.6% | 0.0% |
| Debt-to-Equity | 0.40x | 0.04x | -0.00x |
| Debt-to-EBITDA | 58.76x | 0.40x | 0.00x |
| Equity-to-Assets | 32.3% | 94.3% | -39.3% |
| Net Debt | 4,036 | 112 | -20 |
| Cash & Equivalents | 19 | 6 | 20 |
| Total Debt | 4,055 | 118 | N/A |
| Liquidity & working capital | |||
| Current Ratio | 0.58x | 0.12x | 0.31x |
| Quick Ratio | 0.48x | 0.12x | 0.31x |
| Cash Ratio | 0.00x | 0.08x | 0.02x |
| Total Current Assets | 9,980 | 9 | 420 |
| Total Current Liabilities | 17,089 | 73 | 1,350 |
| Inventory | 1,716 | N/A | N/A |
| Trade Receivables | 7,694 | 1,265 | 260 |
| Trade Payables | 12,084 | N/A | 1,397 |
| Net Working Capital | -7,109 | -64 | -929 |
| Net Working Capital % of Revenue | -8.8% | -2.8% | -65.9% |
| Trade Working Capital | -2,673 | 1,265 | -1,137 |
| Trade Working Capital % of Revenue | -3.3% | 56.3% | -80.6% |
| Change in Trade Working Capital | N/A | N/A | N/A |
| Turnover & efficiency | |||
| Inventory Turnover | 46.19x | N/A | N/A |
| Days Inventory Outstanding (DIO) | 7.9 | N/A | N/A |
| Receivables Turnover | 10.48x | 1.78x | 5.43x |
| Days Sales Outstanding (DSO) | 34.8 | 205.3 | 67.2 |
| Payables Turnover | 6.56x | N/A | 0.47x |
| Days Payable Outstanding (DPO) | 55.6 | N/A | 774.4 |
| Cash Conversion Cycle | -12.9 days | 205.3 days | -707.2 days |
| Asset Turnover | 2.58x | 0.68x | 1.38x |
| Cash flow & dividends | |||
| Operating Cash Flow | 2,600 | -12 | 178 |
| Free Cash Flow (OCF − Capex proxy) | -2,146 | -12 | 59 |
| Cash Conversion (OCF / EBITDA) | 3767.9% | -3.9% | 101.6% |
| Dividends Declared | 1,000 | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |